A detailed history of Oversea Chinese Banking Corp LTD transactions in Novo Nordisk A S stock. As of the latest transaction made, Oversea Chinese Banking Corp LTD holds 20,376 shares of NVO stock, worth $1.59 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
20,376
Previous 10,275 98.31%
Holding current value
$1.59 Million
Previous $1.22 Million 43.25%
% of portfolio
0.05%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$85.0 - $120.04 $858,585 - $1.21 Million
10,101 Added 98.31%
20,376 $1.75 Million
Q3 2024

Nov 04, 2024

BUY
$119.07 - $145.42 $447,941 - $547,070
3,762 Added 57.76%
10,275 $1.22 Million
Q2 2024

Aug 05, 2024

SELL
$122.71 - $146.91 $62,582 - $74,924
-510 Reduced 7.26%
6,513 $929,000
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $717,118 - $954,566
7,023 New
7,023 $901,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $176B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Oversea Chinese Banking Corp LTD Portfolio

Follow Oversea Chinese Banking Corp LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oversea Chinese Banking Corp LTD, based on Form 13F filings with the SEC.

News

Stay updated on Oversea Chinese Banking Corp LTD with notifications on news.